Nutrition delivery for obese ICU patients: Delivery issues, lack of guidelines, and missed opportunities

Robert Martindale, Mark DeLegge, Stephen McClave, Craig Monroe, Vance Smith, Laszlo Kiraly

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The most appropriate enteral formula for the severely obese population has yet to be determined. The obese patient in the intensive care unit (ICU) creates numerous difficulties for managing care, one being the ability to deliver appropriate and timely nutrition. Access for nutrition therapy, either enteral or parenteral, can also create a challenge. Currently, no specific guidelines are available on a national or international scale to address the issues of how and when to feed the obese patient in the ICU. A bias against feeding these patients exists, secondary to the perception that an enormous quantity of calories is stored in adipose tissue. Making a specialty enteral formula for obesity from existing commercial formulas and other modular nutrient components is not practical, secondary to difficulty with solubility issues, dilution of the formula, and safety concerns. Using today's concepts and current metabolic data, a formula could be produced that would address many of the specific metabolic derangements noted in obesity. This formula should have a high-protein, low-carbohydrate content with at least a portion of the lipid source coming from fish oil. Specific nutrients that may be beneficial in obesity include arginine, glutamine, leucine, L-carnitine, lipoic acid, S-adenosylmethionine, and betaine. Certain trace minerals such as magnesium, zinc, and selenium may also be of value in the obese population. The concept of a specific bariatric formulation for the ICU setting is theoretically sound, is scientifically based, and could be delivered to patients safely.

Original languageEnglish (US)
JournalJournal of Parenteral and Enteral Nutrition
Volume35
Issue number5 SUPPL.
DOIs
StatePublished - Sep 2011

Fingerprint

Intensive Care Units
Guidelines
Small Intestine
Obesity
Nutrition Therapy
Bariatrics
Thioctic Acid
Food
S-Adenosylmethionine
Betaine
Carnitine
Fish Oils
Trace Elements
Selenium
Glutamine
Leucine
Solubility
Magnesium
Population
Arginine

Keywords

  • Bariatric
  • Enteral formula
  • Immunomodulation
  • Inflammation
  • Severe obesity

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Nutrition delivery for obese ICU patients : Delivery issues, lack of guidelines, and missed opportunities. / Martindale, Robert; DeLegge, Mark; McClave, Stephen; Monroe, Craig; Smith, Vance; Kiraly, Laszlo.

In: Journal of Parenteral and Enteral Nutrition, Vol. 35, No. 5 SUPPL., 09.2011.

Research output: Contribution to journalArticle

@article{992db7ec225b426fbbff8c23fdfbec5a,
title = "Nutrition delivery for obese ICU patients: Delivery issues, lack of guidelines, and missed opportunities",
abstract = "The most appropriate enteral formula for the severely obese population has yet to be determined. The obese patient in the intensive care unit (ICU) creates numerous difficulties for managing care, one being the ability to deliver appropriate and timely nutrition. Access for nutrition therapy, either enteral or parenteral, can also create a challenge. Currently, no specific guidelines are available on a national or international scale to address the issues of how and when to feed the obese patient in the ICU. A bias against feeding these patients exists, secondary to the perception that an enormous quantity of calories is stored in adipose tissue. Making a specialty enteral formula for obesity from existing commercial formulas and other modular nutrient components is not practical, secondary to difficulty with solubility issues, dilution of the formula, and safety concerns. Using today's concepts and current metabolic data, a formula could be produced that would address many of the specific metabolic derangements noted in obesity. This formula should have a high-protein, low-carbohydrate content with at least a portion of the lipid source coming from fish oil. Specific nutrients that may be beneficial in obesity include arginine, glutamine, leucine, L-carnitine, lipoic acid, S-adenosylmethionine, and betaine. Certain trace minerals such as magnesium, zinc, and selenium may also be of value in the obese population. The concept of a specific bariatric formulation for the ICU setting is theoretically sound, is scientifically based, and could be delivered to patients safely.",
keywords = "Bariatric, Enteral formula, Immunomodulation, Inflammation, Severe obesity",
author = "Robert Martindale and Mark DeLegge and Stephen McClave and Craig Monroe and Vance Smith and Laszlo Kiraly",
year = "2011",
month = "9",
doi = "10.1177/0148607111415532",
language = "English (US)",
volume = "35",
journal = "Journal of Parenteral and Enteral Nutrition",
issn = "0148-6071",
publisher = "SAGE Publications Inc.",
number = "5 SUPPL.",

}

TY - JOUR

T1 - Nutrition delivery for obese ICU patients

T2 - Delivery issues, lack of guidelines, and missed opportunities

AU - Martindale, Robert

AU - DeLegge, Mark

AU - McClave, Stephen

AU - Monroe, Craig

AU - Smith, Vance

AU - Kiraly, Laszlo

PY - 2011/9

Y1 - 2011/9

N2 - The most appropriate enteral formula for the severely obese population has yet to be determined. The obese patient in the intensive care unit (ICU) creates numerous difficulties for managing care, one being the ability to deliver appropriate and timely nutrition. Access for nutrition therapy, either enteral or parenteral, can also create a challenge. Currently, no specific guidelines are available on a national or international scale to address the issues of how and when to feed the obese patient in the ICU. A bias against feeding these patients exists, secondary to the perception that an enormous quantity of calories is stored in adipose tissue. Making a specialty enteral formula for obesity from existing commercial formulas and other modular nutrient components is not practical, secondary to difficulty with solubility issues, dilution of the formula, and safety concerns. Using today's concepts and current metabolic data, a formula could be produced that would address many of the specific metabolic derangements noted in obesity. This formula should have a high-protein, low-carbohydrate content with at least a portion of the lipid source coming from fish oil. Specific nutrients that may be beneficial in obesity include arginine, glutamine, leucine, L-carnitine, lipoic acid, S-adenosylmethionine, and betaine. Certain trace minerals such as magnesium, zinc, and selenium may also be of value in the obese population. The concept of a specific bariatric formulation for the ICU setting is theoretically sound, is scientifically based, and could be delivered to patients safely.

AB - The most appropriate enteral formula for the severely obese population has yet to be determined. The obese patient in the intensive care unit (ICU) creates numerous difficulties for managing care, one being the ability to deliver appropriate and timely nutrition. Access for nutrition therapy, either enteral or parenteral, can also create a challenge. Currently, no specific guidelines are available on a national or international scale to address the issues of how and when to feed the obese patient in the ICU. A bias against feeding these patients exists, secondary to the perception that an enormous quantity of calories is stored in adipose tissue. Making a specialty enteral formula for obesity from existing commercial formulas and other modular nutrient components is not practical, secondary to difficulty with solubility issues, dilution of the formula, and safety concerns. Using today's concepts and current metabolic data, a formula could be produced that would address many of the specific metabolic derangements noted in obesity. This formula should have a high-protein, low-carbohydrate content with at least a portion of the lipid source coming from fish oil. Specific nutrients that may be beneficial in obesity include arginine, glutamine, leucine, L-carnitine, lipoic acid, S-adenosylmethionine, and betaine. Certain trace minerals such as magnesium, zinc, and selenium may also be of value in the obese population. The concept of a specific bariatric formulation for the ICU setting is theoretically sound, is scientifically based, and could be delivered to patients safely.

KW - Bariatric

KW - Enteral formula

KW - Immunomodulation

KW - Inflammation

KW - Severe obesity

UR - http://www.scopus.com/inward/record.url?scp=84855362398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855362398&partnerID=8YFLogxK

U2 - 10.1177/0148607111415532

DO - 10.1177/0148607111415532

M3 - Article

C2 - 21881018

AN - SCOPUS:84855362398

VL - 35

JO - Journal of Parenteral and Enteral Nutrition

JF - Journal of Parenteral and Enteral Nutrition

SN - 0148-6071

IS - 5 SUPPL.

ER -